+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Allergic Fungal Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Fungal Rhinosinusitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recessive Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Hizentra Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Hizentra Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
COSENTYX Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

COSENTYX Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
Psoriatic Arthritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Psoriatic Arthritis - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
From
Methyl Salicylate Market Report and Forecast 2025-2034 - Product Thumbnail Image

Methyl Salicylate Market Report and Forecast 2025-2034

  • Report
  • August 2025
  • 155 Pages
  • Global
From
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more